Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study

Michihi ,  o Iwaki ,  Hideki Fujii 외 42명

Clinical and Molecular Hepatology

2024 .04

Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences

Joo Hyun Oh ,  Dae Won Jun

Clinical and Molecular Hepatology

2024 .04

Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progression

Sumin Oh ,  Yang-Hyun Baek ,  Sungju Jung 외 19명

Clinical and Molecular Hepatology

2024 .04

Liquid biopsy: Where did it come from, what is it, and where is it going?

Todd M. Mo ,  gan

Investigative and Clinical Urology

2019 .01

Sextant Systematic Biopsy Versus Extended 12-Core Systematic Biopsy in Combined Biopsy for Prostate Cancer

Chung Jae Hoon ,  Song Wan ,  Kang Minyong 외 8명

Journal of Korean Medical Science

2024 .02

Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study

Seogsong Jeong ,  Yun Hwan Oh ,  Joseph C Ahn 외 13명

Clinical and Molecular Hepatology

2024 .07

The association of HER2 difference between core needle biopsy and surgical biopsy

Young Hoon JEONG ,  Min-Kyoon KIM

대한외과학회 학술대회 초록집

2019 .10

Is liver biopsy still useful in the era of non-invasive tests?

Tae Seop Lim ,  Ja Kyung Kim

Clinical and Molecular Hepatology

2020 .01

Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia

Hi ,  oyuki Suzuki ,  Tsubasa Tsutsumi 외 3명

Clinical and Molecular Hepatology

2024 .07

Correspondence on Editorial regarding “Identification of signature gene set as highly accurate determination of MASLD progression”

Sungju Jung ,  Sumin Yoon ,  Jong Hoon Pa 외 3명

Clinical and Molecular Hepatology

2024 .04

No More NAFLD: The Term Is Now MASLD

배지철

Endocrinology and Metabolism

2024 .02

Comparison of prostate cancer detection rates of various prostate biopsy methods for patients with prostate-specific antigen levels of <10.0 ng/mL in real-world practice

오경택 ,  구교철 ,  정병하 외 1명

Investigative and Clinical Urology

2020 .01

Changing from NAFLD to MASLD: Similar prognosis of patients with HCC under atezolizumab/bevacizumab treatment between NAFLD and MASLD

Hi ,  oyuki Suzuki ,  Shigeo Shimose 외 3명

Clinical and Molecular Hepatology

2024 .04

간섬유화 진단에서 순간탄성측정법(Transient Elastography)과 간조직검사의 비교 연구

김현진 ,  정양화 ,  진미경 외 2명

대한초음파의료영상학회지

2015 .04

일차치과의원에서의 조직병리검사

한다울 ,  조은애산드라

대한치과의사협회지

2020 .04

Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?

Joo Hyun Oh ,  Dong Hyun Sinn

Clinical and Molecular Hepatology

2023 .04

Effects of Metabolic Dysfunction-Associated Steatotic Liver Disease on Bone Density and Fragility Fractures: Associations and Mechanisms

Shaghayegh Khanmohammadi ,  Mohammad Shafi Kuchay

Journal of Obesity & Metabolic Syndrome

2024 .06

Biopsy or cytology for diagnosing hepatic focal lesions?

Kim Hae ,  young

Clinical and Molecular Hepatology

2021 .01

Efficacy of a Second Brain Biopsy for Intracranial Lesions after Initial Negativity

Mohamed Chabaane ,  Ayme ,  ic Amelot 외 13명

Journal of Clinical Neurology

2020 .01

US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnoses

Glen Geje ,  man ,  Pat 외 21명

Investigative and Clinical Urology

2017 .01